Behavioral and drug therapy for urinary incontinence

Area of Science:

• Gerontology
• Urology
• Behavioral Medicine

Background:

• Urge or mixed incontinence is common in older women.
• Current treatments include drug therapy (e.g., oxybutynin) and behavioral interventions.
• The comparative effectiveness and patient satisfaction of these treatments require further investigation.

Purpose of the Study:

• To compare the efficacy and patient satisfaction of biofeedback-assisted behavioral therapy versus oxybutynin drug therapy for urge or mixed incontinence in older women.
• To explore the potential benefits of behavioral therapy as a practical approach in general practice.

Main Methods:

• A randomized, controlled trial was conducted.
• Participants were older, community-dwelling women with urge or mixed incontinence.
• Treatments compared included biofeedback-assisted behavioral therapy, oxybutynin drug therapy, and placebo.

Main Results:

• Both behavioral therapy and oxybutynin were superior to placebo.
• Behavioral therapy showed a significantly higher reduction in incontinence (80.7%) compared to oxybutynin (68.5%, P = 0.04).
• Patient satisfaction was markedly higher with behavioral therapy (97% willingness to continue) than with drug therapy (55%).

Conclusions:

• Biofeedback-assisted behavioral therapy is a highly effective and preferred treatment for urge or mixed incontinence in older women.
• Behavioral therapy, even without biofeedback, offers significant clinical benefits and is a practical option for general practice.
• Combination therapy may provide further improvements, though treatment mechanisms remain unclear.